CN Patent

CN116239532B — 一种二氯四氢异喹啉羧酸的中间体及其制备方法和应用

Assigned to Shanghai Pharmaceutical Industry Research Institute Co ltd · Expires 2023-11-07 · 3y expired

What this patent protects

本发明提供了一种式Ⅱ所示的化合物及其合成方法和应用，涉及药物化学合成领域。所述式Ⅱ所示的化合物可以用于合成立他司特的关键中间体，即5,7‑二氯‑1,2,3,4‑四氢异喹啉‑6‑羧酸。本发明具有收率高、纯化操作简便等优点，适合于工业上大规模生产。

USPTO Abstract

本发明提供了一种式Ⅱ所示的化合物及其合成方法和应用，涉及药物化学合成领域。所述式Ⅱ所示的化合物可以用于合成立他司特的关键中间体，即5,7‑二氯‑1,2,3,4‑四氢异喹啉‑6‑羧酸。本发明具有收率高、纯化操作简便等优点，适合于工业上大规模生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN116239532B
Jurisdiction
CN
Classification
—
Expires
2023-11-07
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceutical Industry Research Institute Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.